Skip to content

The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke

The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07347327
Enrollment
28
Registered
2026-01-16
Start date
2023-01-01
Completion date
2025-12-29
Last updated
2026-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia

Brief summary

This clinical trial aims to study whether dual-target transcranial alternating current stimulation (tACS) applied to the auditory and motor brain region can improve repetition disorder in people with stroke, and to evaluate the safety of tACS. The main goals are to answer the following questions: 1. Can dual-tACS stimulation of the auditory and motor brain area improve repetition functions in people with aphasia after stroke? 2. Can it improve the integration of auditory information and speech motor control during communication? Researchers will compare the effects of real tACS versus sham (placebo) stimulation to see if real stimulation leads to better outcomes in aphasia patients. Participants will: 1. Receive one extra 20-minute session of either real or sham tACS each day for 10 days 2. Attend clinic visits before and after 10-days stimulation for clinical assessments(WAB) and fNIRS recording related brain activity

Interventions

BEHAVIORALspeech training

speech training(especially repetition training) synchronized with tACS stimulation

dual-target tACS on auditory and motor brain area at a frequency of 8 Hz,with individualized current intensity, delivered for 20 minutes.

except for turning down the current intensity to zero during the 20-minute period, all other parameters are identical to those in real group.

Sponsors

Ke Dong, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Meeting the diagnostic criteria for hemorrhagic or ischemic stroke in the Chinese Guidelines for the Prevention and Treatment of Cerebrovascular Diseases(2nd edition), with the first onset, single hemisphere stroke, and confirmed by CT or MRI,course of diease 1-6 months; * Age ranging from 30 to 80 years old; * Native language is Mandarin or Cantonese; * Right-handed; * Diagnosed with aphasia by the Western Aphasia Battery (WAB) scale; * Able to cooperate in completing the speech repetition test; * Normal hearing.

Exclusion criteria

* Currently receiving non-invasive brain stimulation treatment; * Lesions involving the Broca or STG brain regions; * History of epilepsy, mental illness,or other neurological or mental disorders; * Any contraindications for transcranial electrical stimulation.

Design outcomes

Primary

MeasureTime frameDescription
Western Aphasia Battery (WAB) scoreBaseline and 10-daysWestern Aphasia Battery (WAB) score:0-100,higher score means better language function

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026